Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Essentia Pura is a European-based company specializing in the research, development, and production of high-quality hemp extracts and supercritical CO2 extraction systems. The company serves as a contract manufacturer (CMO) and wholesale supplier of cannabinoid-based ingredients, including CBD, CBG, and terpenes, for the pharmaceutical, nutraceutical, and cosmetic industries. Their core expertise lies in utilizing advanced CO2 extraction technology to produce pure, solvent-free bioactive compounds. In addition to ingredient manufacturing, Essentia Pura provides professional consulting, product formulation services, and custom extraction equipment to global partners. The company is recognized for its commitment to GMP standards and scientific innovation in the field of natural plant extracts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Essentia Pura.